Physician

Pankaj Khandelwal, MD

According to 2025 Medicare claims, Pankaj Khandelwal, MD (NPI: 1114964756) practices medical oncology in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 79761-5010.

Khandelwal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 484 traditional Medicare patients, billed 171,309 HCPCS/CPT codes, and received $3,464,610 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,580 prescription claims across 226 beneficiaries totaling $3,064,628 in drug costs, led by Ibrance (Palbociclib). DME data shows 24 claims. Open Payments data shows 5 records totaling $46,142. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,186,613 to $3,464,610. Similarly, Part D prescription costs have risen steadily, from $1,174,564 to $3,064,628. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.5M2015 Medicare payment: $1,186,613 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,483,970 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,280,676 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,232,226 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,315,082 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,421,088 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,874,026 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,445,359 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,272,958 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,464,610 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201537497,230$1,186,613
2016540107,530$1,483,970
201760794,190$1,280,676
201852084,990$1,232,226
201947797,468$1,315,082
202042984,205$1,421,088
2021427108,082$1,874,026
2022469145,737$2,445,359
2023485167,522$2,272,958
2024484171,309$3,464,610

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.1M2015 Drug cost: $1,174,564 (USD; Tot_Drug_Cst)2016 Drug cost: $1,012,656 (USD; Tot_Drug_Cst)2017 Drug cost: $1,261,559 (USD; Tot_Drug_Cst)2018 Drug cost: $1,656,665 (USD; Tot_Drug_Cst)2019 Drug cost: $1,602,989 (USD; Tot_Drug_Cst)2020 Drug cost: $1,454,519 (USD; Tot_Drug_Cst)2021 Drug cost: $1,687,980 (USD; Tot_Drug_Cst)2022 Drug cost: $1,847,985 (USD; Tot_Drug_Cst)2023 Drug cost: $2,171,774 (USD; Tot_Drug_Cst)2024 Drug cost: $3,064,628 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151811,410$1,174,564
20162121,549$1,012,656
20172161,581$1,261,559
20182131,558$1,656,665
20191921,357$1,602,989
2020164954$1,454,519
20211911,141$1,687,980
20222071,225$1,847,985
20232301,505$2,171,774
20242261,580$3,064,628

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.3K$6.6K2015 Medicare payment: $6,569 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,811 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,150 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,679 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,171 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $3,926 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $497 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R124$6,569
2016N/R90$4,811
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R12$1,150
2021N/R36$2,679
2022N/R48$1,171
2023N/R38$3,926
2024N/R24$497

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less118442$95
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more158315$92
80053Blood test, comprehensive group of blood chemicals222506$10
36415Insertion of needle into vein for collection of blood sample218659$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count218619$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib421,200$648,715
RevlimidLenalidomide25700$435,099
ImbruvicaIbrutinib17476$251,016
XtandiEnzalutamide18510$226,478
LenalidomideLenalidomide19532$215,903

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R11$287
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R13$210

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.5$46,142AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Pankaj Khandelwal, MD?

Tedicare shows public-source Medicare data for Pankaj Khandelwal, MD (NPI 1114964756), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pankaj Khandelwal, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Pankaj Khandelwal, MD?

Pankaj Khandelwal, MD is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Pankaj Khandelwal, MD have Open Payments data?

Pankaj Khandelwal, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.